| No images? Click here  Wednesday, 17 March 2021 SAGE recommendations on the WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization today issued interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine. See also:
About SAGE: The Strategic Advisory Group of Experts (SAGE) on Immunization is charged with advising WHO on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions. A SAGE Working Group on COVID-19 Vaccines was established in June 2020 and consists of 26 experts who have been considering all aspects that would inform policy recommendations, including values, ethics, clinical trial data, and programmatic considerations. SAGE provides guidance for overall COVID-19 vaccination programme strategy, as well as vaccine-specific recommendations:
SAGE COVID-19 vaccine-specific recommendations:
For more information, visit https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization/working-groups  Media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list.  |
Wednesday, March 17, 2021
SAGE recommendations on the Janssen Ad26.COV2.S (COVID-19) vaccine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment